Portrait
Display Documents Help
all 127
author's publication 127
primary author 22
Person [unauthorized form]
Source: bibliographic databases
Main Heading
Melichar, Bohuslav
Affiliation
-
Affiliation
a Department of Oncology , Palacký University Medical School Teaching Hospital , Olomouc , Czech Republic. b Institute of Molecular and Translational Medicine , Palacký University Medical School Teaching Hospital , Olomouc , Czech Republic.
Affiliation
CCLM Associate Editor, Palacky University Medical School, Oncology, Olomouc, Czech Republic.
Affiliation
Department of Oncology and Radiotherapy, Charles University Medical School and Teaching Hospital, Hradec Králové, Czech Republic. bohuslav.melichar@fnol.cz; Department of Oncology, Palacký University Medical School and Teaching Hospital, Olomouc, Czech Republic
Affiliation
Department of Oncology Palacký University Medical School Teaching Hospital, Olomouc, Czech Republic. bohuslav.melichar@fnol.cz
Affiliation
Department of Oncology, Faculty of Medicine & Dentistry & University Hospital, Palacky University, Olomouc, Czech Republic.
Affiliation
Department of Oncology, Faculty of Medicine & Dentistry, Palacky University Olomouc, University Hospital Olomouc, Czech Republic. Institute of Molecular & Translational Medicine, Faculty of Medicine & Dentistry, Palacky University, Olomouc, Czech Republic.
Affiliation
Department of Oncology, Faculty of Medicine and Dentistry and University Hospital, Palacky University, I.P. Pavlova 6, 775 20, Olomouc, Czech Republic.
Affiliation
Department of Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital in Olomouc, Olomouc, Czech Republic.
Affiliation
Department of Oncology, Faculty of Medicine and Dentistry, Palacký University and University Hospital, I.P. Pavlova 6, 775 20 Olomouc, Czech Republic.
Affiliation
Department of Oncology, Faculty of Medicine and Dentistry, Palacký University and University Hospital, I.P. Pavlova 6, 775 20, Olomouc, Czech Republic.
Affiliation
Department of Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, 771 47 Olomouc, Czech Republic. Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic.
Affiliation
Department of Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic. Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic.
Affiliation
Department of Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Hněvotínská 3, CZ-779 00, Olomouc, Czech Republic.
Affiliation
Department of Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic.
Affiliation
Department of Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic.
Affiliation
Department of Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc, University Hospital Olomouc, 77520 Olomouc, Czech Republic.
Affiliation
Department of Oncology, Faculty of Medicine and Dentistry, Palacky University, and University Hospital Olomouc, Olomouc, Czech Republic.
Affiliation
Department of Oncology, Faculty of Medicine and Dentistry, Palacky University, Hnevotinska 976/3, 775 15 Olomouc, Czech Republic. Bohuslav.Melichar@fnol.cz.
Affiliation
Department of Oncology, Faculty of Medicine and Dentistry, Palacky University, Hnevotinska 976/3, 77515 Olomouc, Czech Republic. bohuslav.melichar@upol.cz.
Affiliation
Department of Oncology, Faculty of Medicine and Dentistry, Palacky University, Olomouc - Czech Republic.
Affiliation
Department of Oncology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic. Institute of Molecular and Translational Medicine Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
Affiliation
Department of Oncology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic. Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, University Hospital in Olomouc, Olomouc, Czech Republic.
Affiliation
Department of Oncology, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic, d.beatrice@seznam.cz.
Affiliation
Department of Oncology, Palacky University Medical and Teaching Hospital, Olomouc, Czech Republic.
Affiliation
Department of Oncology, Palacký University Medical School & Teaching Hospital, I.P. Pavlova 6, 775 20 Olomouc, Czech Republic. bohuslav.melichar@fnol.cz
Affiliation
Department of Oncology, Palacký University Medical School & Teaching Hospital, Olomouc, Czech Republic Department of Oncology & Radiotherapy, Charles University Medical School & Teaching Hospital, Hradec Králové, Czech Republic Fourth Department of Medicine, Charles University Medical School & Teaching Hospital, Hradec Králové, Czech Republic bohuslav.melichar@fnol.cz.
Affiliation
Department of Oncology, Palacký University Medical School and Teaching Hospital Olomouc, Olomouc, Czech Republic
Affiliation
Department of Oncology, Palacky University Medical School and Teaching Hospital Olomouc, Olomouc, Czechia.
Affiliation
Department of Oncology, Palacky University Medical School and Teaching Hospital, 775 20 Olomouc, Czech Republic.
Affiliation
Department of Oncology, Palacky University Medical School and Teaching Hospital, 779 00 Olomouc, Czech Republic. University Hospital in Hradec Kralove, 500 05 Hradec Kralove, Czech Republic.
Affiliation
Department of Oncology, Palacký University Medical School and Teaching Hospital, Fakultní nemocnice, Olomouc, Czech Republic. bohuslav.melichar@fnol.cz
Affiliation
Department of Oncology, Palacky University Medical School and Teaching Hospital, I.P. Pavlova 6, 775 20 Olomouc, Czech Republic.
Affiliation
Department of Oncology, Palacký University Medical School and Teaching Hospital, I.P. Pavlova 6, 775 20 Olomouc, Czech Republic. bohuslav.melichar@fnol.cz
Affiliation
Department of Oncology, Palacky University Medical School and Teaching Hospital, I.P. Pavlova 6, 775 20, Olomouc, Czech Republic.
Affiliation
Department of Oncology, Palacky University Medical School and Teaching Hospital, I.P. Pavlova 6, 77520, Olomouc, Czech Republic. bohuslav.melichar@fnol.cz.
Affiliation
Department of Oncology, Palacky University Medical School and Teaching Hospital, IP Pavlova 6, 775 20, Olomouc, Czech Republic.
Affiliation
Department of Oncology, Palacký University Medical School and Teaching Hospital, Olomouc, Czech Republic Institute of Molecular and Translational Medicine, Palacký University Medical School and Teaching Hospital, Olomouc, Czech Republic.
Affiliation
Department of Oncology, Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic.
Affiliation
Department of Oncology, Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic. bohuslav.melichar@fnol.cz
Affiliation
Department of Oncology, Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic. bohuslav.melichar@fnol.cz.
Affiliation
Department of Oncology, Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic. bohuslav.melichar@fnol.cz; Institute of Experimental Neurosurgery, Charles University Medichal School and Teaching Hospital, Hradec Králové, Czech Republic
Affiliation
Department of Oncology, Palacký University Medical School and Teaching Hospital, Olomouc, Czech Republic. Department of Oncology and Radiotherapy, Charles University Medical School & Teaching Hospital, Hradec Králové, Czech Republic. Fourth Department of Medicine, Charles University Medical School & Teaching Hospital, Hradec Králové, Czech Republic.
Affiliation
Department of Oncology, Palacký University Medical School and Teaching Hospital, Olomouc, Czech Republic. Electronic address: bohuslav.melichar@fnol.cz.
Affiliation
Department of Oncology, Palacký University Medical School and Teaching Hospital, Olomouc, Czech Republic; Department of Oncology and Radiotherapy, Charles University Medical School and Teaching Hospital, Hradec Kralove, Czech Republic. bohuslav.melichar@fnol.cz
Affiliation
Department of Oncology, Palacky University Medical School and University Hospital Olomouc, Křížkovského 8, 771 47, Olomouc, Czech Republic.
Affiliation
Department of Oncology, Palacky University Medical School and University Hospital Olomouc, Olomouc, Czech Republic.
Affiliation
Department of Oncology, Palacky University Medical School, Olomouc, Czech Republic.
Affiliation
Department of Oncology, Palacky University, and University Hospital Olomouc, Olomouc, Czech Republic.
Affiliation
Department of Oncology, Palacký University, Faculty of Medicine and Dentistry and University Hospital, Olomouc, Czech Republic. Institute of Molecular and Translational Medicine, Palacký University, Faculty of Medicine and Dentistry and University Hospital, Olomouc, Czech Republic.
Affiliation
Department of Oncology, Palacky University, Faculty of Medicine and Dentistry, Olomouc, Czech Republic.
Affiliation
Department of Oncology, University Hospital, Olomouc, Czech Republic.
Affiliation
Dept of Oncology, Palacký University Medical School and Teaching Hospital, I.P. Pavlova 6, 775 20, Olomouc, Czech Republic.
Affiliation
Fourth Department of Medicine, Charles University Medical School Teaching Hospital, Hradec Kralove, Czech Republic.
Affiliation
From Memorial Sloan Kettering Cancer Center, New York (R.J.M.), and Roswell Park Cancer Institute, Buffalo (S.G.) - both in New York; University of Texas M.D. Anderson Cancer Center, Houston (N.M.T., P. Sharma); Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center (D.F.M.), and Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School (T.K.C.), Boston; Centro Internacional de Estudios Clínicos (O.A.F.) and Fundación Arturo López Pérez (P. Salman), Santiago, Chile; Palacký University and University Hospital Olomouc, Olomouc, Czech Republic (B.M.); Fox Chase Cancer Center, Philadelphia (E.R.P.); Hôpitaux Universitaires de Strasbourg, Strasbourg (P.B.), Bordeaux University Hospital, Hôpital Saint-André, Bordeaux (A.R.), and Institut Gustave Roussy, Villejuif (B.E.) - all in France; Istituto di Ricovero e Cura a Carattere Scientifico San Matteo University Hospital Foundation, Pavia (C.P.), and Ospedale San Donato, Azienda Unità Sanitaria Locale Toscana Sud-Est, Istituto Toscano Tumori, Arezzo (S.B.) - both in Italy; Barts Cancer Institute, Cancer Research UK Experimental Cancer Medicine Centre, Queen Mary University of London, Royal Free NHS Trust (T.P.), and Cancer Research UK (R.H.), London; Aarhus University Hospital, Aarhus, Denmark (F.D.); Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, and Tel Aviv University, Tel Aviv - both in Israel (V.N.); British Columbia Cancer Agency, Vancouver, Canada (C.K.K.); Westmead Hospital and Macquarie University, Sydney (H.G.); Jena University Hospital, Jena, Germany (M.-O.G.); Centro de Pesquisa em Oncologia, Hospital São Lucas, Porto Alegre, Brazil (C.H.B.); Niigata University, Niigata, Japan (Y.T.); Hospital Universitario 12 de Octubre, Madrid (D.C.); Cleveland Clinic Taussig Cancer Institute, Cleveland (B.I.R.); Bristol-Myers Squibb, Princeton, NJ (A.C.C., S.M., M.B.M., M.W.-R., J.D.); and Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore (H.J.H.).
Affiliation
From the Cleveland Clinic Taussig Cancer Institute, Cleveland (B.I.R.); Fox Chase Cancer Center, Philadelphia (E.R.P.); Dnipropetrovsk Medical Academy of Ministry of Health of Ukraine (V.S.) and Dnipropetrovsk Medical Academy (I.B.), Dnipro, Sumy State University, Sumy Regional Oncology Center, Sumy (I.V.), and Ivano-Frankivsk National Medical University, Ivano-Frankivsk (A.K.) - all in Ukraine; the Russian Scientific Center of Roentgen Radiology (R.G.), Central Clinical Hospital with Outpatient Clinic (D.N.), and Hertzen Moscow Cancer Research Institute (B.A.), Moscow; the Christie NHS Foundation Trust, Manchester (R.H.), and Barts Health and the Royal Free NHS Trusts, Barts Cancer Institute, and Queen Mary University of London, London (T.P.) - all in the United Kingdom; Centre Hospitalier Universitaire (CHU) de Québec and Université Laval, Quebec, QC (F.P.), and CHU de Montréal, Montreal (D.S.) - both in Canada; Palacký University Medical School and Teaching Hospital, Olomouc, Czech Republic (B.M.); Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil (S.J.A.); Centre Antoine Lacassagne, Université Côte d'Azur, Nice (D.B.), and Hôpitaux Universitaires de Lyon, Lyon (S. Tartas) - both in France; Military Institute of Medicine, Warsaw, Poland (C.S.); Rocky Mountain Cancer Center, Colorado Springs, CO (M.M.); Adelaide and Meath Hospital and University College Dublin, Dublin (R.S.M.); the Department of Urology, Eberhard-Karls University Tübingen, Tübingen, Germany (J.B.); Taipei Veterans General Hospital, Taipei, Taiwan (Y.-H.C.); Osaka City University Hospital, Osaka, Japan (S. Tamada); MSD China, Beijing (Q.S.); Merck, Kenilworth, NJ (R.F.P., M.C.); and Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.B.A.).
Affiliation
From the Erasmus Medical Center, Rotterdam, the Netherlands (R.W.); the Institute of Cancer Research and the Royal Marsden Hospital, London (J.B.); Englander Institute for Precision Medicine, Weill Cornell Medicine, New York (C.N.S.); Institut Gustave Roussy and University of Paris Sud, Villejuif (K.F.), Jean Godinot Institute and Reims Champagne-Ardenne University, Reims (J.-C.E.), Foch Hospital, Suresnes (C.T.), Hôpital d'Instruction des Armées Bégin, Saint Mandé (C.H.), and Sanofi, Europe Medical Oncology, Paris (C.G.-R.) - all in France; Institut de Recherche Clinique, Université Catholique de Louvain, Louvain, Belgium (B.T.); the Department of Urology, Asklepios Tumorzentrum Hamburg, Asklepios Klinik Altona, Hamburg (C.W.), and Studienpraxis Urologie, Nürtingen (S.F.) - both in Germany; the Medical University of Vienna, Vienna (G.K.); Alexandra Hospital, National and Kapodistrian University of Athens, Athens (A.B.); Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona (J.C.); Azienda Ospedaliera Universitaria Integrata, Verona, and Fondazione Policlinico Agostino Gemelli IRCCS, Rome - both in Italy (R.I.); Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic (B.M.); Landspitali University Hospital, Reykjavik, Iceland (Á.S.); Sanofi, Global Medical Oncology, Cambridge, MA (A.O.); and 12 de Octubre University Hospital, Madrid (D.C.).
Affiliation
Charles Univ. Prague, Fac. Med. and Univ. Hospital, Depts. IInd Intern. Med., Hradec Králové
Affiliation
Charles Univ. Prague, Fac. Med. and Univ. Hospital, Depts. Oncol. Radioth, Hradec Králové
Affiliation
Charles Univ. Prague, Fac. Med. and Univ. Hospital, Depts. Oncol., Hradec Králové
Affiliation
Charles Univ. Prague, Fac. Med., Depts. Oncol. Radiother., Hradec Králové
Affiliation
Institute of Experimental Neurosurgery, Charles University Medichal School and Teaching Hospital, Hradec Králové, Czech Republic; Department of Oncology, Palacký University Medical School and Teaching Hospital, Olomouc, Czech Republic
Affiliation
Institute of Experimental Neurosurgery, Charles University School of Medicine, Hradec Králové, Czech Republic; Department of Oncology, Palacký University Medical School and Teaching Hospital, Olomouc, Czech Republic
Affiliation
Lékařská Fakulta Univerzita Palackého a Fakultní Nemocnice Olomouc, Olomouc, Czech Republic.
Affiliation
Medical School and Teaching Hospital, Department of Oncology, Palacký University, I.P. Pavlova 6, 775 20, Olomouc, Czech Republic.
Affiliation
Onkologicka klinika, Lekarska fakulta Univerzity Palackeho a Fakultni nemocnice, I.P. Pavlova, 6, Olomouc 779 00, Czech Republic.
Affiliation
Onkologicka klinika, Lekarska fakulta Univerzity Palackeho a Fakultni nemocnice, Olomouc, Czech Republic.
Affiliation
Onkologická klinika, LF UP a FN, Olomouc
Affiliation
Palacký University Medical School & Teaching Hospital, Department of Oncology, I. P. Pavlova 185/6, 779 00, Olomouc, Czech Republic.
Affiliation
Palacky University Medical School and Teaching Hospital, I.P. Pavlova 6, Olomouc, Czech Republic.
Affiliation
Palacký University Medical School and Teaching Hospital, Olomouc, Czech Republic.
Affiliation
Palacký University, Medical School and Teaching Hospital, Department of Oncology, I.P. Pavlova 6, 775 20 Olomouc, Czech Republic.
Affiliation
Palacký University, Medical School and Teaching Hospital, Department of Oncology, I.P.Pavlova 6, 77520, Olomouc, Czech Republic.
Affiliation
Professor and Head, Department of Oncology, Palacký University Medical School & Teaching Hospital, I.P. Pavlova 6, 775 20 Olomouc, Czech Republic. bohuslav.melichar@fnol.cz
Affiliation
Robert J. Motzer and Paul Russo, Memorial Sloan Kettering Cancer Center, New York, NY; Naomi B. Haas, University of Pennsylvania, Philadelphia, PA; Frede Donskov, Aarhus University Hospital, Aarhus, Denmark; Marine Gross-Goupil, Bordeaux University Hospital, Bordeaux, France; Sergei Varlamov, Altai Regional Cancer Center, Barnaul; Evgeny Kopyltsov, State Institution of Healthcare Regional Clinical Oncology Dispensary, Omsk, Russia; Jae Lyun Lee, University of Ulsan College of Medicine; Ho Yeong Lim, Sungkyunkwan University, Seoul, Republic of Korea; Bohuslav Melichar, Palacky University Medical School and Teaching Hospital, Olomouc; Milada Zemanova, Charles University and General University Hospital, Prague, Czech Republic; Brian I. Rini, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Toni K. Choueiri, Dana-Farber Cancer Institute, Boston, MA; Lori A. Wood, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia; M. Neil Reaume, Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada; Arnulf Stenzl, University Hospital Tübingen, Tübingen; Christian Doehn, University of Lübeck Medical School and Urologikum Lübeck, Lübeck, Germany; Simon Chowdhury, Guy's and St Thomas' National Health Service Foundation/St Thomas' Hospital, London; Ray McDermott, Tallaght University Hospital and Cancer Trials Ireland, Dublin; Agnieszka Michael, University of Surrey, Guildford, United Kingdom; Weichao Bao, Marlene J. Carrasco-Alfonso, and Maurizio Voi, Novartis Oncology, East Hanover, NJ; Paola Aimone, Novartis Pharma AG, Basel, Switzerland; and Cora N. Sternberg, San Camillo Forlanini Hospital, Rome, Italy.
Affiliation
The Department of Oncology, Palacký University Olomouc, Faculty of Medicine and Dentistry, I.P. Pavlova 6, 779 00 Olomouc, Czech Republic.
Display format